Portugal’s medicines regulator has defended a year of tightened oversight and extended licensing delays throughout the country’s medical cannabis sector, telling operators that export certificates are now issued within 12 days and that the enforcement which unsettled the market stemmed from record-keeping and traceability failures rather than problems with the product itself.
As reported by Cannareporter Portugal remains well positioned to be one of the main producers of medicinal cannabis in the world.
Last month, Portugal’s government announced plans to establish a working group to explore the regulation of adult-use cannabis, with a conclusion expected by the end of the year.
PRESS RELEASE CLEVER Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today that its facility in Portugal has been granted EU-GMP certification by the Portuguese Health Authority (INFARMED, I.P.) to manufacture dried cannabis flower as an active pharmaceutical ingredient and as finished product.
